Related Experiment Videos
Immunological aspects of diabetes
1Clinic of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania.
Recenti Progressi in Medicina
|February 1, 1990
Summary
Type 1 diabetes is an autoimmune disease linked to HLA class II genes and characterized by various autoantibodies. Current research focuses on understanding cell-mediated immunity and developing immunotherapies like Cyclosporin A.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes is a chronic autoimmune disease.
- It involves immune system attacks on pancreatic beta-cells.
- Genetic factors, particularly HLA class II genes, play a significant role.
Purpose of the Study:
- To review progress in understanding the immunology of Type 1 diabetes.
- To explore the role of immunogenetics and autoantibodies.
- To discuss therapeutic advancements and challenges.
Main Methods:
- Review of immunogenetic studies.
- Analysis of autoantibody profiles (ICA, ICSA, CF-ICA, etc.).
- Assessment of cell-mediated immunity changes, including T cell activation.
Main Results:
- Strong association between Type 1 diabetes and HLA class II genes (e.g., HLA-DR3, DR4).
- Identification of multiple autoantibodies with potential pathogenic and predictive roles.
- Increased activated T cells suggest their involvement in beta-cell destruction.
- Insulin autoantibodies (IAA) are emerging markers of autoimmunity.
Conclusions:
- Type 1 diabetes is a multi-stage autoimmune process leading to beta-cell destruction.
- Highly purified insulins are developed to mitigate immunogenicity issues.
- Immunotherapy, such as Cyclosporin A, shows promise but requires careful application.